Treatment of immune system with .DELTA.5-androstenes
US5585371A · kind A · utility
37Cited by
15References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 2, 1994 |
| Grant date | Dec 17, 1996 |
| Priority date | — |
| Expiry date | Feb 2, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Immune system response may be enhanced by administering a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.